First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Stock Price Down 0.7% – Here’s What Happened

Posted by Paula Ricardo on Jun 9th, 2026

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) dropped 0.7% during mid-day trading on Monday . The stock traded as low as $221.15 and last traded at $221.15. Approximately 21,871 shares were traded during mid-day trading, a decline of 84% from the average daily volume of 139,583 shares. The stock had previously closed at $222.75.

First Trust NYSE Arca Biotechnology Index Fund Stock Down 0.7%

The business’s 50-day moving average price is $208.89 and its 200 day moving average price is $208.66. The company has a market capitalization of $2.50 billion, a P/E ratio of 21.72 and a beta of 0.68.

Hedge Funds Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Large investors have recently modified their holdings of the company. High Point Wealth Management LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter valued at approximately $26,000. Russell Investments Group Ltd. raised its stake in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% in the third quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after purchasing an additional 158 shares in the last quarter. Rossby Financial LCC raised its stake in First Trust NYSE Arca Biotechnology Index Fund by 160.0% in the third quarter. Rossby Financial LCC now owns 169 shares of the company’s stock valued at $31,000 after purchasing an additional 104 shares in the last quarter. AG Campbell Advisory LLC purchased a new stake in First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter valued at approximately $31,000. Finally, Capital Investment Advisory Services LLC raised its stake in First Trust NYSE Arca Biotechnology Index Fund by 63.1% in the third quarter. Capital Investment Advisory Services LLC now owns 181 shares of the company’s stock valued at $32,000 after purchasing an additional 70 shares in the last quarter.

About First Trust NYSE Arca Biotechnology Index Fund

(Get Free Report)

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.